Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Long-Term Treatment with OnabotulinumtoxinA Results in Consistent, Durable Improvements in Health Related Quality of Life in Patients with Overactive Bladder
David A. Ginsberg, Marcus J. Drake, Albert Kaufmann, et al.
The Journal of Urology (2017) Vol. 198, Iss. 4, pp. 897-904
Closed Access | Times Cited: 21

Showing 21 citing articles:

Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders
Martin C. Michel, Linda Cardozo, Christopher Chermansky, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 4, pp. 554-674
Closed Access | Times Cited: 34
The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis
Jure Tornic, Jalesh N. Panicker
Current Neurology and Neuroscience Reports (2018) Vol. 18, Iss. 8
Open Access | Times Cited: 77
Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis
Joseph Jankovic, Jean Carruthers, Markus Naumann, et al.
Toxins (2023) Vol. 15, Iss. 5, pp. 342-342
Open Access | Times Cited: 17
Treatment of neurogenic detrusor overactivity and overactive bladder with Botox (onabotulinumtoxinA): Development, insights, and impact
Victor W. Νitti, Cornelia Haag‐Molkenteller, Michael Kennelly, et al.
Medicine (2023) Vol. 102, Iss. S1, pp. e32377-e32377
Open Access | Times Cited: 15
National Patterns of Filled Prescriptions and Third-Line Treatment Utilization for Privately Insured Women With Overactive Bladder
Brian J. Linder, John B. Gebhart, Daniel S. Elliott, et al.
Female Pelvic Medicine & Reconstructive Surgery (2019) Vol. 27, Iss. 2, pp. e261-e266
Closed Access | Times Cited: 28
Novel Applications of OnabotulinumtoxinA in Lower Urinary Tract Dysfunction
Jia‐Fong Jhang, Hann‐Chorng Kuo
Toxins (2018) Vol. 10, Iss. 7, pp. 260-260
Open Access | Times Cited: 17
Management of spinal cord injury patients with neurogenic lower urinary tract dysfunction using minimally invasive and surgical therapies in Taiwan
Sheng‐Fu Chen, Hann‐Chorng Kuo
International Urology and Nephrology (2023) Vol. 56, Iss. 4, pp. 1205-1216
Closed Access | Times Cited: 5
Misinformation on the Internet regarding Ablative Therapies for Prostate Cancer
Denise Asafu‐Adjei, Nina Mikkilineni, Elisabeth M. Sebesta, et al.
Urology (2019) Vol. 133, pp. 182-186
Closed Access | Times Cited: 15
Complications of Botox and their Management
Rose Leu, Gillian Stearns
Current Urology Reports (2018) Vol. 19, Iss. 11
Closed Access | Times Cited: 15
Trigonal‐sparing versus trigonal‐involved Botox injection for treatment of idiopathic overactive bladder: A randomized clinical trial
Ahmed S. El‐Hefnawy, M. A. Elbaset, Diaa‐Eldin Taha, et al.
LUTS Lower Urinary Tract Symptoms (2020) Vol. 13, Iss. 1, pp. 22-30
Closed Access | Times Cited: 13
Diagnosis and management of overactive bladder: A review
Victor W. Νitti, Anand Patel, Mickey M. Karram
Journal of Obstetrics and Gynaecology Research (2021) Vol. 47, Iss. 5, pp. 1654-1665
Closed Access | Times Cited: 12
Individualizing medical treatment of overactive bladder
Hann‐Chorng Kuo
Tzu Chi Medical Journal (2018) Vol. 30, Iss. 4, pp. 195-195
Open Access | Times Cited: 6
Shifting the treatment paradigm in idiopathic overactive bladder
Arun Sahai, Mo Belal, Rizwan Hamid, et al.
International Journal of Clinical Practice (2020) Vol. 75, Iss. 4
Open Access | Times Cited: 5
Factors Associated With Onabotulinum Toxin-A Discontinuation in a Diverse Urban Population
Tyler Bergeron, Arshia Aalami Harandi, Mariel J. Liebeskind, et al.
Urogynecology (2024) Vol. 30, Iss. 12, pp. 949-955
Closed Access
Satisfaction with bladder management in community-dwelling patients with chronic spinal cord injury
Tianhai Huang, Sheng‐Fu Chen, Sheng‐Mou Hsiao
Journal of the Formosan Medical Association (2024)
Open Access
Interventionelle/operative Therapie der Dranginkontinenz
D. Schultz‐Lampel, Ricarda M. Bauer, Albert Kaufmann
Elsevier eBooks (2024), pp. 131-145
Closed Access
Antibiotic use, best practice statement adherence, and UTI rate for intradetrusor onabotulinumtoxin‐A injection for overactive bladder: A multi‐institutional collaboration from the SUFU Research Network (SURN)
Katherine Shapiro, Jennifer T. Anger, Anne P. Cameron, et al.
Neurourology and Urodynamics (2023) Vol. 43, Iss. 2, pp. 407-414
Open Access | Times Cited: 1
Quality of Life in Female Patients with Overactive Bladder after Botulinum Toxin Treatment
Agnieszka A. Licow-Kamińska, Sylwester Ciećwież, Magdalena Ptak, et al.
Toxins (2023) Vol. 16, Iss. 1, pp. 7-7
Open Access
Clinical Factors to Decide Between Sacral Neuromodulation and Onabotulinum Toxin—When Is One Clearly Better?
Laura Nguyen, Esther Han, Alec Wilson, et al.
Current Bladder Dysfunction Reports (2017) Vol. 12, Iss. 4, pp. 328-336
Closed Access
Reply by Authors
Heidi S. Harvie, Cindy L. Amundsen, Simon Neuwahl, et al.
The Journal of Urology (2020) Vol. 203, Iss. 5, pp. 977-977
Open Access
Treatments for Lower Urinary Tract Dysfunction
Sharon Yeo, Hashim Hashim
(2021), pp. 73-91
Closed Access
Page 1

Scroll to top